AIM ImmunoTech (AIM) Earnings Date & Reports

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AIM is expected to report earnings to fall 10.00% to -9 cents per share on May 15

AIM ImmunoTech AIM Stock Earnings Reports

Q1'25

Est.

$-0.09

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.09

Q1'24

Est.

$-0.12

The last earnings report on March 27 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 156.80K shares outstanding, the current market capitalization sits at 8.32M.

View a ticker or compare two or three

Compare

AIM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AIM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2117 SW Highway 484

Phone

+1 352 448-7797

Employees

Web

https://www.aimimmuno.com